Revised forecast
Fiscal year ending April 2026 · Full yearPrevious forecast published 15 December 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Operating profit exceeded forecast due to expanded domestic sales in the Cosmetics Business, improvements in cost of sales resulting from lower product valuation losses and other factors, company-wide cost controls, reduced losses in new businesses, and contributions from overseas subsidiaries. Lower-than-initially-expected extraordinary losses and tax expenses, among other items, also contributed to the upside in net income.
| Item | Details |
|---|---|
| Net Sales | ¥21,673 million → ¥22,073 million（+1.8%） |
| Operating profit | ¥723 million → ¥983 million（+36.0%） |
| Ordinary income | ¥479 million → ¥761 million（+58.9%） |
| Profit attributable to owners of the parent | ¥152 million → ¥541 million（+255.9%） |
| Net income per share | 9.33 yen → 33.85 yen |
| Fiscal Period Covered | Fiscal year ending April 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 15 December 2025 |
| Previous-period results | Revenue: ¥22,895 million; operating profit: ¥2,354 million; ordinary profit: ¥2,352 million; net income attributable to owners of the parent: ¥1,278 million; basic earnings per share: ¥80.15 (fiscal year ended April 2025) |
| Reason for the revision | Operating profit exceeded forecast due to expanded domestic sales in the Cosmetics Business, improvements in cost of sales resulting from lower product valuation losses and other factors, company-wide cost controls, reduced losses in new businesses, and contributions from overseas subsidiaries. Lower-than-initially-expected extraordinary losses and tax expenses, among other items, also contributed to the upside in net income. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Operating profit exceeded forecast due to expanded domestic sales in the Cosmetics Business, improvements in cost of sales resulting from lower product valuation losses, company-wide cost controls including head office expenses, reduced losses in new businesses, and contributions from overseas subsidiaries. In addition, extraordinary losses and tax expenses, among other items, were lower than initially expected, resulting in a substantial upside in net income attributable to owners of the parent.